Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 02, 2021, titled "Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID‐19 treatment in India and other Asian markets".